Neogen Corporation (NEOG)
NASDAQ: NEOGHealthcareMedical DevicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 11.65 -0.26%
NEOG stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.55B
- Forward P/E
- 30.74
- EPS (TTM)
- -$0.26
- Dividend yield
- None
- 52-week range
- 5.37 – 14.26
- Day range
- 11.37 – 12.92
- Volume / Avg
- 12.96M / 2.84M
- Beta
- —
- Shares outstanding
- 218.11M
52-week range
NEOG stock today
Neogen (NEOG) closed at $11.68 on Oct 7, down 2.34% (-$0.28), versus the S&P 500's 0.22% decline. Volume was 4.6x the average at 12.96M shares, a sign of unusually heavy trading. Shares are 18.1% below their 52-week high of $14.26, set on Sep 23, 2026 and 117.5% above the 52-week low of $5.37, in the middle of the past year's range.
NEOG is up 67.1% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 108.9%. Neogen has posted a net loss over the last twelve months (EPS of -$0.26), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Neogen
Company profileNeogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. Mikhael Nassif
- Headquarters
- Lansing, MI
- Employees
- 2,636
- IPO year
- 1989
- Website
- neogen.com
Analyst forecast
ForecastConsensus (4 analysts)
buy
Avg. price target
$14.00+19.86%
- Strong buy 2
- Buy 1
- Hold 1
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
NEOG news
All NEOG newsNeogen peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TMDXTransMedics Group Inc. | 81.07 | +0.98% | $2.81B | vs NEOG |
| UFPTUFP Technologies Inc. | 292.87 | -3.30% | $2.27B | vs NEOG |
| BFLYButterfly Network Inc. Class A | 8.27 | -4.94% | $2.20B | vs NEOG |
| AXGNAxogen Inc. | 36.04 | -0.74% | $2.11B | vs NEOG |
| INSPInspire Medical Systems Inc. | 67.45 | -1.10% | $1.95B | vs NEOG |
| ALMRAlamar Biosciences Inc. | 27.77 | -13.92% | $1.93B | vs NEOG |
| ESTAEstablishment Labs Holdings Inc. | 63.85 | -2.21% | $1.90B | vs NEOG |
| IRTCiRhythm Holdings Inc. | 104.99 | -2.06% | $3.46B | vs NEOG |
Indexes, lists and sector
Appears in lists
Neogen stock FAQ
What is Neogen's stock price today?
NEOG last traded at $11.68 as of Oct 7, 4:00 PM EDT, down 2.34% on the day. Prices are delayed at least 15 minutes.
Does Neogen pay a dividend?
No. Neogen does not currently pay a regular cash dividend.
Who is Neogen's CEO?
Mr. Mikhael Nassif is the chief executive officer of Neogen Corporation, which has about 2,636 employees.
Has NEOG ever split its stock?
Yes. The most recent NEOG stock split was a 2-for-1 split on Jun 7, 2021, one of 6 splits on record.
What is the NEOG 52-week high?
The 52-week high for NEOG is $14.26 and the 52-week low is $5.37. The stock is currently 18.1% below its high.